Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 221

1.

Deep sequencing of 2009 influenza A/H1N1 virus isolated from volunteer human challenge study participants and natural infections.

Xiao Y, Park JK, Williams S, Ramuta M, Cervantes-Medina A, Bristol T, Smith S, Czajkowski L, Han A, Kash JC, Memoli MJ, Taubenberger JK.

Virology. 2019 Jun 13;534:96-107. doi: 10.1016/j.virol.2019.06.004. [Epub ahead of print]

PMID:
31226666
2.

Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection.

Walters KA, Zhu R, Welge M, Scherler K, Park JK, Rahil Z, Wang H, Auvil L, Bushell C, Lee MY, Baxter D, Bristol T, Rosas LA, Cervantes-Medina A, Czajkowski L, Han A, Memoli MJ, Taubenberger JK, Kash JC.

MBio. 2019 May 14;10(3). pii: e00760-19. doi: 10.1128/mBio.00760-19.

3.

Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies.

Gao J, Couzens L, Burke DF, Wan H, Wilson P, Memoli MJ, Xu X, Harvey R, Wrammert J, Ahmed R, Taubenberger JK, Smith DJ, Fouchier RAM, Eichelberger MC.

MBio. 2019 Apr 9;10(2). pii: e00307-19. doi: 10.1128/mBio.00307-19.

4.

Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine Development.

Memoli MJ, Han A, Walters KA, Czajkowski L, Reed S, Athota R, Rosas LA, Cervantes-Medina A, Park JK, Morens DM, Kash JC, Taubenberger JK.

Clin Infect Dis. 2019 Apr 6. pii: ciz281. doi: 10.1093/cid/ciz281. [Epub ahead of print]

PMID:
30953061
5.

A Dose Finding Study of a Wild-Type Influenza A/H3N2 virus in a Healthy Volunteer Human Challenge Model.

Han A, Czajkowski LM, Donaldson A, Baus HA, Reed SM, Athota RS, Bristol T, Rosas LA, Cervantes-Medina A, Taubenberger JK, Memoli MJ.

Clin Infect Dis. 2019 Feb 16. pii: ciz141. doi: 10.1093/cid/ciz141. [Epub ahead of print]

PMID:
30770534
6.

Making Universal Influenza Vaccines: Lessons From the 1918 Pandemic.

Morens DM, Taubenberger JK.

J Infect Dis. 2019 Apr 8;219(Supplement_1):S5-S13. doi: 10.1093/infdis/jiy728.

PMID:
30715352
7.

Influenza Cataclysm, 1918.

Morens DM, Taubenberger JK.

N Engl J Med. 2018 Dec 13;379(24):2285-2287. doi: 10.1056/NEJMp1814447. No abstract available.

PMID:
30575465
8.

Mutation of Influenza A Virus PA-X Decreases Pathogenicity in Chicken Embryos and Can Increase the Yield of Reassortant Candidate Vaccine Viruses.

Hussain S, Turnbull ML, Wise HM, Jagger BW, Beard PM, Kovacikova K, Taubenberger JK, Vervelde L, Engelhardt OG, Digard P.

J Virol. 2019 Jan 4;93(2). pii: e01551-18. doi: 10.1128/JVI.01551-18. Print 2019 Jan 15.

9.

The Mother of All Pandemics Is 100 Years Old (and Going Strong)!

Morens DM, Taubenberger JK.

Am J Public Health. 2018 Nov;108(11):1449-1454. doi: 10.2105/AJPH.2018.304631. Epub 2018 Sep 25.

PMID:
30252528
10.

Deep Sequencing of H7N9 Influenza A Viruses from 16 Infected Patients from 2013 to 2015 in Shanghai Reveals Genetic Diversity and Antigenic Drift.

Xiao YL, Ren L, Zhang X, Qi L, Kash JC, Xiao Y, Wu F, Wang J, Taubenberger JK.

mSphere. 2018 Sep 19;3(5). pii: e00462-18. doi: 10.1128/mSphereDirect.00462-18.

11.

Design and validation of a universal influenza virus enrichment probe set and its utility in deep sequence analysis of primary cloacal swab surveillance samples of wild birds.

Xiao Y, Nolting JM, Sheng ZM, Bristol T, Qi L, Bowman AS, Taubenberger JK.

Virology. 2018 Nov;524:182-191. doi: 10.1016/j.virol.2018.08.021. Epub 2018 Sep 10.

PMID:
30212665
12.

Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness.

Eichelberger MC, Morens DM, Taubenberger JK.

Curr Opin Immunol. 2018 Aug;53:38-44. doi: 10.1016/j.coi.2018.03.025. Epub 2018 Apr 16. Review.

PMID:
29674167
13.

Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus.

Park JK, Han A, Czajkowski L, Reed S, Athota R, Bristol T, Rosas LA, Cervantes-Medina A, Taubenberger JK, Memoli MJ.

MBio. 2018 Jan 23;9(1). pii: e02284-17. doi: 10.1128/mBio.02284-17.

14.

Differential Ability of Pandemic and Seasonal H1N1 Influenza A Viruses To Alter the Function of Human Neutrophils.

Malachowa N, Freedman B, Sturdevant DE, Kobayashi SD, Nair V, Feldmann F, Starr T, Steele-Mortimer O, Kash JC, Taubenberger JK, Feldmann H, DeLeo FR.

mSphere. 2018 Jan 3;3(1). pii: e00567-17. doi: 10.1128/mSphereDirect.00567-17. eCollection 2018 Jan-Feb.

15.

Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.

Wan H, Qi L, Gao J, Couzens LK, Jiang L, Gao Y, Sheng ZM, Fong S, Hahn M, Khurana S, Taubenberger JK, Eichelberger MC.

J Virol. 2018 Jan 30;92(4). pii: e01588-17. doi: 10.1128/JVI.01588-17. Print 2018 Feb 15.

16.

Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease.

Kash JC, Walters KA, Kindrachuk J, Baxter D, Scherler K, Janosko KB, Adams RD, Herbert AS, James RM, Stonier SW, Memoli MJ, Dye JM, Davey RT Jr, Chertow DS, Taubenberger JK.

Sci Transl Med. 2017 Apr 12;9(385). pii: eaai9321. doi: 10.1126/scitranslmed.aai9321.

17.

IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity.

Wang TT, Sewatanon J, Memoli MJ, Wrammert J, Bournazos S, Bhaumik SK, Pinsky BA, Chokephaibulkit K, Onlamoon N, Pattanapanyasat K, Taubenberger JK, Ahmed R, Ravetch JV.

Science. 2017 Jan 27;355(6323):395-398. doi: 10.1126/science.aai8128.

18.

Role of the B Allele of Influenza A Virus Segment 8 in Setting Mammalian Host Range and Pathogenicity.

Turnbull ML, Wise HM, Nicol MQ, Smith N, Dunfee RL, Beard PM, Jagger BW, Ligertwood Y, Hardisty GR, Xiao H, Benton DJ, Coburn AM, Paulo JA, Gygi SP, McCauley JW, Taubenberger JK, Lycett SJ, Weekes MP, Dutia BM, Digard P.

J Virol. 2016 Sep 29;90(20):9263-84. doi: 10.1128/JVI.01205-16. Print 2016 Oct 15.

19.

Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model.

Memoli MJ, Shaw PA, Han A, Czajkowski L, Reed S, Athota R, Bristol T, Fargis S, Risos K, Powers JH, Davey RT Jr, Taubenberger JK.

MBio. 2016 Apr 19;7(2):e00417-16. doi: 10.1128/mBio.00417-16.

20.

1918 Influenza receptor binding domain variants bind and replicate in primary human airway cells regardless of receptor specificity.

Davis AS, Chertow DS, Kindrachuk J, Qi L, Schwartzman LM, Suzich J, Alsaaty S, Logun C, Shelhamer JH, Taubenberger JK.

Virology. 2016 Jun;493:238-46. doi: 10.1016/j.virol.2016.03.025. Epub 2016 Apr 11.

21.

Universal Influenza Vaccines: To Dream the Possible Dream?

Park JK, Taubenberger JK.

ACS Infect Dis. 2016 Jan 8;2(1):5-7. Epub 2015 Dec 18.

22.

Influenza A and methicillin-resistant Staphylococcus aureus co-infection in rhesus macaques - A model of severe pneumonia.

Chertow DS, Kindrachuk J, Sheng ZM, Pujanauski LM, Cooper K, Nogee D, Claire MS, Solomon J, Perry D, Sayre P, Janosko KB, Lackemeyer MG, Bohannon JK, Kash JC, Jahrling PB, Taubenberger JK.

Antiviral Res. 2016 May;129:120-129. doi: 10.1016/j.antiviral.2016.02.013. Epub 2016 Feb 26.

23.

1918 pandemic influenza virus and Streptococcus pneumoniae co-infection results in activation of coagulation and widespread pulmonary thrombosis in mice and humans.

Walters KA, D'Agnillo F, Sheng ZM, Kindrachuk J, Schwartzman LM, Kuestner RE, Chertow DS, Golding BT, Taubenberger JK, Kash JC.

J Pathol. 2016 Jan;238(1):85-97. doi: 10.1002/path.4638. Epub 2015 Oct 14.

24.

Influenza Circulation in United States Army Training Camps Before and During the 1918 Influenza Pandemic: Clues to Early Detection of Pandemic Viral Emergence.

Chertow DS, Cai R, Sun J, Grantham J, Taubenberger JK, Morens DM.

Open Forum Infect Dis. 2015 Apr 2;2(2):ofv021. doi: 10.1093/ofid/ofv021. eCollection 2015 Apr.

25.

Isolating Viral and Host RNA Sequences from Archival Material and Production of cDNA Libraries for High-Throughput DNA Sequencing.

Xiao Y, Sheng ZM, Taubenberger JK.

Curr Protoc Microbiol. 2015 May 1;37:1E.8.1-16. doi: 10.1002/9780471729259.mc01e08s37.

26.

Recombinant H7 hemagglutinin forms subviral particles that protect mice and ferrets from challenge with H7N9 influenza virus.

Pushko P, Pujanauski LM, Sun X, Pearce M, Hidajat R, Kort T, Schwartzman LM, Tretyakova I, Chunqing L, Taubenberger JK, Tumpey TM.

Vaccine. 2015 Sep 11;33(38):4975-82. doi: 10.1016/j.vaccine.2015.07.026. Epub 2015 Jul 21.

27.

An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus.

Schwartzman LM, Cathcart AL, Pujanauski LM, Qi L, Kash JC, Taubenberger JK.

MBio. 2015 Jul 21;6(4):e01044. doi: 10.1128/mBio.01044-15.

28.

A forgotten epidemic that changed medicine: measles in the US Army, 1917-18.

Morens DM, Taubenberger JK.

Lancet Infect Dis. 2015 Jul;15(7):852-61. doi: 10.1016/S1473-3099(15)00109-7. Epub 2015 Jun 9. Review.

PMID:
26070967
29.

The role of viral, host, and secondary bacterial factors in influenza pathogenesis.

Kash JC, Taubenberger JK.

Am J Pathol. 2015 Jun;185(6):1528-36. doi: 10.1016/j.ajpath.2014.08.030. Epub 2015 Mar 5. Review.

30.

The use of nonhuman primates in research on seasonal, pandemic and avian influenza, 1893-2014.

Davis AS, Taubenberger JK, Bray M.

Antiviral Res. 2015 May;117:75-98. doi: 10.1016/j.antiviral.2015.02.011. Epub 2015 Mar 5. Review.

31.

Validation of normal human bronchial epithelial cells as a model for influenza A infections in human distal trachea.

Davis AS, Chertow DS, Moyer JE, Suzich J, Sandouk A, Dorward DW, Logun C, Shelhamer JH, Taubenberger JK.

J Histochem Cytochem. 2015 May;63(5):312-28. doi: 10.1369/0022155415570968. Epub 2015 Jan 20.

32.

Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study.

Memoli MJ, Czajkowski L, Reed S, Athota R, Bristol T, Proudfoot K, Fargis S, Stein M, Dunfee RL, Shaw PA, Davey RT, Taubenberger JK.

Clin Infect Dis. 2015 Mar 1;60(5):693-702. doi: 10.1093/cid/ciu924. Epub 2014 Nov 20.

33.

Contemporary avian influenza A virus subtype H1, H6, H7, H10, and H15 hemagglutinin genes encode a mammalian virulence factor similar to the 1918 pandemic virus H1 hemagglutinin.

Qi L, Pujanauski LM, Davis AS, Schwartzman LM, Chertow DS, Baxter D, Scherler K, Hartshorn KL, Slemons RD, Walters KA, Kash JC, Taubenberger JK.

MBio. 2014 Nov 18;5(6):e02116. doi: 10.1128/mBio.02116-14.

34.

How low is the risk of influenza A(H5N1) infection?

Morens DM, Taubenberger JK.

J Infect Dis. 2015 May 1;211(9):1364-6. doi: 10.1093/infdis/jiu530. Epub 2014 Oct 29. No abstract available.

PMID:
25355943
35.

Pneumocystis encodes a functional endo-β-1,3-glucanase that is expressed exclusively in cysts.

Kutty G, Davis AS, Ma L, Taubenberger JK, Kovacs JA.

J Infect Dis. 2015 Mar 1;211(5):719-28. doi: 10.1093/infdis/jiu517. Epub 2014 Sep 17.

36.

Characterizing and Diminishing Autofluorescence in Formalin-fixed Paraffin-embedded Human Respiratory Tissue.

Davis AS, Richter A, Becker S, Moyer JE, Sandouk A, Skinner J, Taubenberger JK.

J Histochem Cytochem. 2014 Jun;62(6):405-423. Epub 2014 Apr 10.

37.

Reply to Wilson et al.

Viboud C, Eisenstein J, Reid AH, Janczewski TA, Morens DM, Taubenberger JK.

J Infect Dis. 2014 Sep 15;210(6):995-7. doi: 10.1093/infdis/jiu192. Epub 2014 Mar 27. No abstract available.

38.

Flu season: An interview with Jeffery K. Taubenberger, Chief of the Viral Pathogenesis and Evolution Section at the US National Institute of Allergy and Infectious Diseases.

Taubenberger JK, Breithaupt H.

EMBO Rep. 2014 Mar;15(3):212-7. doi: 10.1002/embr.201438423. Epub 2014 Feb 7. No abstract available.

39.

A possible outbreak of swine influenza, 1892.

Morens DM, Taubenberger JK.

Lancet Infect Dis. 2014 Feb;14(2):169-72. doi: 10.1016/S1473-3099(13)70227-5. Epub 2013 Nov 28.

40.

Characterization of the noncoding regions of the 1918 influenza A H1N1 virus.

Wang R, Taubenberger JK.

J Virol. 2014 Feb;88(3):1815-8. doi: 10.1128/JVI.03098-13. Epub 2013 Nov 13.

41.

The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts.

Memoli MJ, Athota R, Reed S, Czajkowski L, Bristol T, Proudfoot K, Hagey R, Voell J, Fiorentino C, Ademposi A, Shoham S, Taubenberger JK.

Clin Infect Dis. 2014 Jan;58(2):214-24. doi: 10.1093/cid/cit725. Epub 2013 Nov 1.

42.

Treatment with the reactive oxygen species scavenger EUK-207 reduces lung damage and increases survival during 1918 influenza virus infection in mice.

Kash JC, Xiao Y, Davis AS, Walters KA, Chertow DS, Easterbrook JD, Dunfee RL, Sandouk A, Jagger BW, Schwartzman LM, Kuestner RE, Wehr NB, Huffman K, Rosenthal RA, Ozinsky A, Levine RL, Doctrow SR, Taubenberger JK.

Free Radic Biol Med. 2014 Feb;67:235-47. doi: 10.1016/j.freeradbiomed.2013.10.014. Epub 2013 Oct 17.

43.

Seasonal H3N2 influenza A virus fails to enhance Staphylococcus aureus co-infection in a non-human primate respiratory tract infection model.

Kobayashi SD, Olsen RJ, LaCasse RA, Safronetz D, Ashraf M, Porter AR, Braughton KR, Feldmann F, Clifton DR, Kash JC, Bailey JR, Gardner DJ, Otto M, Brining DL, Kreiswirth BN, Taubenberger JK, Parnell MJ, Feldmann H, Musser JM, DeLeo FR.

Virulence. 2013 Nov 15;4(8):707-15. doi: 10.4161/viru.26572. Epub 2013 Oct 8.

44.

Rapid sequencing of influenza A virus vRNA, cRNA and mRNA non-coding regions.

Wang R, Xiao Y, Taubenberger JK.

J Virol Methods. 2014 Jan;195:26-33. doi: 10.1016/j.jviromet.2013.09.005. Epub 2013 Oct 4.

45.

Reply to "'BUt nature started it': examining Taubenberger and Morens' view on influenza a virus and dual-use research of concern".

Taubenberger JK, Morens DM.

MBio. 2013 Aug 20;4(4). pii: e00579-13. doi: 10.1128/mBio.00579-13. No abstract available.

46.

Influenza viruses: breaking all the rules.

Taubenberger JK, Morens DM.

MBio. 2013 Jul 16;4(4). pii: e00365-13. doi: 10.1128/mBio.00365-13.

47.

H7N9 avian influenza A virus and the perpetual challenge of potential human pandemicity.

Morens DM, Taubenberger JK, Fauci AS.

MBio. 2013 Jul 9;4(4). pii: e00445-13. doi: 10.1128/mBio.00445-13. Review.

48.

Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses.

Wan H, Gao J, Xu K, Chen H, Couzens LK, Rivers KH, Easterbrook JD, Yang K, Zhong L, Rajabi M, Ye J, Sultana I, Wan XF, Liu X, Perez DR, Taubenberger JK, Eichelberger MC.

J Virol. 2013 Aug;87(16):9290-300. doi: 10.1128/JVI.01203-13. Epub 2013 Jun 19.

49.

HASP server: a database and structural visualization platform for comparative models of influenza A hemagglutinin proteins.

Ambroggio XI, Dommer J, Gopalan V, Dunham EJ, Taubenberger JK, Hurt DE.

BMC Bioinformatics. 2013 Jun 18;14:197. doi: 10.1186/1471-2105-14-197.

50.

Pandemic influenza viruses--hoping for the road not taken.

Morens DM, Taubenberger JK, Fauci AS.

N Engl J Med. 2013 Jun 20;368(25):2345-8. doi: 10.1056/NEJMp1307009. Epub 2013 Jun 5. No abstract available.

Supplemental Content

Loading ...
Support Center